
Innate Pharma SA
PAR:IPH

Wall Street
Price Targets
IPH Price Targets Summary
Innate Pharma SA
According to Wall Street analysts, the average 1-year price target for
IPH
is 5.27 EUR
with a low forecast of 2.45 EUR and a high forecast of 8.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IPH's stock price target?
Price Target
5.27
EUR
According to Wall Street analysts, the average 1-year price target for
IPH
is 5.27 EUR
with a low forecast of 2.45 EUR and a high forecast of 8.82 EUR.
What is Innate Pharma SA's Revenue forecast?
Projected CAGR
79%
For the last 8 years the
compound annual growth rate for
Innate Pharma SA's revenue is
-17%.
The projected
CAGR
for the next 3 years is
79%.